Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

NorthWest Healthcare Properties Real Estate Invest 10 Convert Sub Debentures 31 March 2025 T.NWH.DB.I


Primary Symbol: T.NWH.DB.G Alternate Symbol(s):  NWHUF | T.NWH.UN | T.NWH.DB.H

Northwest Healthcare Properties Real Estate Investment Trust is an open-ended real estate investment trust. The Company is the owner and operator of healthcare real estate infrastructure in North America, Brazil, Europe and Australasia. The principal business of the Company is to invest in healthcare real estate globally. It focuses on the cure segment of healthcare real estate, such as hospitals, medical office buildings, and clinics. Its asset class segmentation includes hospitals and healthcare facilities; medical office buildings; and life sciences, research, and education. It provides investors with access to a portfolio of international healthcare real estate infrastructure of interests in a diversified portfolio of about 196 income-producing properties located throughout major markets in North America, Brazil, Europe and Australasia. Its portfolio of medical office buildings, clinics, and hospitals is characterized by long-term indexed leases and stable occupancies.


TSX:NWH.DB.G - Post by User

Post by incomedreamer11on Aug 14, 2024 10:44am
619 Views
Post# 36178451

Scotia comments on result

Scotia comments on result

Glance: Q2 Miss on Higher G&A and Brazil; Much Improved Balance Sheet Is the Key Catalyst

OUR TAKE: Net-net slightly positive. Is Q2 miss enough to offset good news on UK portfolio sale (penny wise, pound foolish?). We don’t think so. We expect NWH unit price to outperform tomorrow.

(-) Q2 miss: Reported FFOPU of $0.091 below Scotia and consensus estimate of $0.106 (wide range $0.09-$0.13). See Exhibit 1 for variance. Miss due to higher G&A and lower NOI from Brazil (f/x also responsible). Core markets Australasia and Europe beat. So, net-net we are okay with Q2 results.

(+) UK portfolio sale pre-announced: On 8th Aug, NWH announced sale of UK portfolio for $885M at 5.9% cap rate. NWH recorded $105M of FV loss due to sale which equated to 10.6% of IFRS value as of Q1/24. This should be seen in the context of IFRS valuation relative to current unit price. Revised IFRS NAVPU is $9.53 (-$0.83 q/q mainly due to UK sale). Current price implies 48% discount to IFRS NAV. Interestingly, NWH mentioned that they received >10 offers with significant local and international interest.

(+) Balance Sheet risk profile improved: 27% of total debt maturity in 2025 vs 42% previously. $873M of total debt repaid since Q1/24 at average rate of 7.6%. Pro forma leverage reduction by ~5.5 points to ~55% from ~61% (Proportionate Debt/GBV).

(+) High-interest bearing debt being repaid post UK portfolio sale: NWH to repay (i) $140M of Brazil debt at 11.3% interest rate with 2025 expiry. (ii) $460M of UK debt at 6.2% interest rate with 2025 expiry. (iii) $95M of corporate debt with 9.42% interest rate and 2025 expiry. Link to our recent note post UK portfolio sale.

(+) More progress on asset dispositions: Total dispositions of $400M in H1/24 with $234M disposed in Q2. Including Q3 sales, total dispositions at $1.3B in 2024 so far.

(=) Operational portfolio continues to perform well: SP NOI grew +4.2% y/y in Q2 (+6.0% in Q1). SP grew across the geographies (no one region outlier as such). Portfolio occupancy is unchanged q/q at 96.5% with a WALT of 13.2 years, which is one of the longest in our coverage.

(=) IFRS NAVPU decreased 8% q/q to $9.53 (from $10.36 in Q1): FV loss was $175M this Q ($73M in Q1) vs an average of $88M loss in the last four quarters. IFRS cap rate now at 6.22% vs 6.0% last q (up 22bp q/q).

(=) Majority of the AUHPT proceeds were redeemed so far: As expected, NWH received $20.3M from its investment in AUHPT in Q2. Proceeds were used to repay Australasian term debt which was secured by the investments in AUHPT. NWH redeemed a total of $170M of its investment in unlisted securities so far, with the proceeds used to repay balances outstanding on credit facilities.

Full update post @10am ET conf call tomorrow.


<< Previous
Bullboard Posts
Next >>